Healthcare / Health Information ServicesParis
$3.24
+0.04 (+1.25%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-800415.00 · quality 60.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$52M
P/E
54.0x
↑EV/EBITDA
52.6x
↑ROE
12.9%
↑Gross Margin
95.3%
↑Debt/Equity
0.29
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.4%
FCF CAGR
—
FCF margin
10.3%
FCF / Net income
0.72x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $7.0M · net income $986695.0 · FCF $714760.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.0M | $7.0M | $5.3M | $5.6M | $8.7M |
| Net Income | $986695.00 | $986695.00 | $285170.00 | $54363.00 | $1.1M |
| EBITDA | $1.0M | $1.0M | $334058.00 | $45425.00 | $651064.00 |
| EPS | — | — | 0.02 | 0.00 | 0.07 |
| Gross Margin | 95.3% | 95.3% | 90.7% | 86.9% | 95.1% |
| Operating Margin | 4.2% | 4.2% | -9.1% | -11.7% | 0.7% |
| Net Margin | 14.2% | 14.2% | 5.3% | 1.0% | 12.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.29 | 0.29 | 0.34 | 0.51 | 0.39 |
| Current Ratio | 3.08 | 3.08 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $714760.00 | $714760.00 | $-2.3M | — | — |
| Returns | |||||
| ROE | 12.9% | 12.9% | 3.8% | 0.8% | 16.4% |
| Valuation | |||||
| P/E | 54.00 | 54.00 | 138.86 | 2874.93 | 210.62 |
| EV/EBITDA | 52.56 | 52.56 | 124.75 | 3468.33 | 360.21 |
| P/B | 6.82 | 6.82 | 5.29 | 23.10 | 34.48 |
| Growth & Yield | |||||
| Revenue Growth | 30.4% | 30.4% | -5.0% | -35.8% | — |
| EPS Growth | — | — | 425.1% | -95.1% | — |
| Dividend Yield | 3.4% | 3.4% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-36.6%
Start / end P/E
n/dx → n/dx
EPS bridge
0.02 → n/d
Residual
-40.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.